Literature DB >> 19352390

Prostatitis: no benefit of alpha-blockers for chronic prostatitis.

Florian M E Wagenlehner1, Wolfgang Weidner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19352390     DOI: 10.1038/nrurol.2009.45

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  10 in total

1.  AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations.

Authors: 
Journal:  J Urol       Date:  2003-08       Impact factor: 7.450

2.  Clinical practice. Chronic prostatitis and the chronic pelvic pain syndrome.

Authors:  Anthony J Schaeffer
Journal:  N Engl J Med       Date:  2006-10-19       Impact factor: 91.245

Review 3.  Pharmacology of alpha1-adrenoceptor antagonists in the lower urinary tract and central nervous system.

Authors:  Karl-Erik Andersson; Christian Gratzke
Journal:  Nat Clin Pract Urol       Date:  2007-07

Review 4.  Role of alpha-adrenergic blockers in the treatment of benign prostatic hyperplasia.

Authors:  H Lepor
Journal:  Prostate Suppl       Date:  1990

5.  Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial.

Authors:  Richard B Alexander; Kathleen J Propert; Anthony J Schaeffer; J Richard Landis; J Curtis Nickel; Michael P O'Leary; Michel A Pontari; Mary McNaughton-Collins; Daniel A Shoskes; Craig V Comiter; Nand S Datta; Jackson E Fowler; Robert B Nadler; Scott I Zeitlin; Jill S Knauss; Yanlin Wang; John W Kusek; Leroy M Nyberg; Mark S Litwin
Journal:  Ann Intern Med       Date:  2004-10-19       Impact factor: 25.391

6.  Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome.

Authors:  J Curtis Nickel; John N Krieger; Mary McNaughton-Collins; Rodney U Anderson; Michel Pontari; Daniel A Shoskes; Mark S Litwin; Richard B Alexander; Paige C White; Richard Berger; Robert Nadler; Michael O'Leary; Men Long Liong; Scott Zeitlin; Shannon Chuai; J Richard Landis; John W Kusek; Leroy M Nyberg; Anthony J Schaeffer
Journal:  N Engl J Med       Date:  2008-12-18       Impact factor: 91.245

7.  Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study.

Authors:  Aare Mehik; Peeter Alas; J Curtis Nickel; Ari Sarpola; Pekka J Helström
Journal:  Urology       Date:  2003-09       Impact factor: 2.649

8.  Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial.

Authors:  Phaik Yeong Cheah; Men Long Liong; Kah Hay Yuen; Chu Leong Teh; Timothy Khor; Jin Rong Yang; Hin Wai Yap; John N Krieger
Journal:  J Urol       Date:  2003-02       Impact factor: 7.450

9.  Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial.

Authors:  J Curtis Nickel; Perinchery Narayan; John McKay; Caroline Doyle
Journal:  J Urol       Date:  2004-04       Impact factor: 7.450

Review 10.  The concept of neurogenic inflammation.

Authors:  Pierangelo Geppetti; Romina Nassini; Serena Materazzi; Silvia Benemei
Journal:  BJU Int       Date:  2008-03       Impact factor: 5.588

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.